We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

64 hedge funds and large institutions have $286M invested in ProQR Therapeutics in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 6

158% more capital invested

Capital invested by funds: $111M → $286M (+$175M)

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

39% more funds holding

Funds holding: 46 → 64 (+18)

33.6% more ownership

Funds ownership: 52.68% → 86.28% (+34%)

21% more call options, than puts

Call options by funds: $2.48M | Put options by funds: $2.06M

Holders
64
Holders Change
+18
Holders Change %
+39.13%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
23
Reduced
10
Closed
6
Calls
$2.48M
Puts
$2.06M
Net Calls
+$425K
Net Calls Change
+$494K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.8M
2
DCM
Driehaus Capital Management
Illinois
+$10.9M
3
RCM
RA Capital Management
Massachusetts
+$10.8M
4
Citigroup
Citigroup
New York
+$9.63M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$7.78M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$5.02M
2
Morgan Stanley
Morgan Stanley
New York
-$2.73M
3
UBS Group
UBS Group
Switzerland
-$1.95M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.41M
5
Millennium Management
Millennium Management
New York
-$741K
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
51
Cubist Systematic Strategies
Connecticut
$101K +$78.4K +15,345 New
FRM
52
Fox Run Management
Connecticut
$95K +$73.4K +14,361 New
AG
53
Algert Global
California
$75K +$57.7K +11,300 New
MF
54
Magnetar Financial
Illinois
$75K +$58.3K +11,411 New
Wells Fargo
55
Wells Fargo
California
$73K – – –
ECM
56
ExodusPoint Capital Management
New York
$71K -$104K -20,402 -66%
KAS
57
Kestra Advisory Services
Texas
$66K – – –
LC
58
Lindbrook Capital
California
$63K +$46K +9,000 +1,500%
CAPTRUST Financial Advisors
59
CAPTRUST Financial Advisors
North Carolina
$50K +$38.3K +7,500 New
CG
60
Cutler Group
California
$27K +$19.9K +3,900 +1,300%
BlackRock
61
BlackRock
New York
$12K -$118K -23,075 -92%
Fifth Third Bancorp
62
Fifth Third Bancorp
Ohio
$7K – – –
EWM
63
Edge Wealth Management
New York
$1K – – –
AG
64
Artal Group
Luxembourg
– -$5.02M -1,196,218 Closed
Renaissance Technologies
65
Renaissance Technologies
New York
– -$1.41M -335,300 Closed
E
66
Ergoteles
New York
– -$104K -24,800 Closed
GG
67
Golden Green
South Carolina
– -$71K -16,999 Closed
D.E. Shaw & Co
68
D.E. Shaw & Co
New York
– -$53K -12,591 Closed
Barclays
69
Barclays
United Kingdom
– -$16.1K -3,153 -99%
BNP Paribas Financial Markets
70
BNP Paribas Financial Markets
France
– -$2.1K -500 Closed
1 2
3

PRQR Hedge Fund Activity: Q1 2021 in Review

64 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q1 2021, worth a combined $286M — up 158% from $111M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PRQR positions and 6 closed out — a net gain of 18 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $23.8M. The largest seller was Artal Group, exiting entirely with an estimated $5.02M sold.

  • 64 institutional investors held ProQR Therapeutics (PRQR) as of Q1 2021, up from 46 in Q4 2020.
  • Funds reported $286M of ProQR Therapeutics stock for Q1 2021, up 158% quarter-over-quarter.
  • 24 funds opened new ProQR Therapeutics positions in Q1 2021 and 6 closed out, a net change of +18 holders.
  • The largest ProQR Therapeutics buyer in Q1 2021 was Fidelity Investments, an estimated $23.8M added.
  • The largest ProQR Therapeutics seller in Q1 2021 was Artal Group, an estimated $5.02M sold.

Based on aggregated 13F filings for Q1 2021.